20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T71944 | FGF/PDGF/VEGF RTK Inhibitor | ||
FGF/PDGF/VEGF RTK Inhibitor is a potent, reversible, atp-competitive inhibitor against pdgfrβ, fgfr-1, and vegfr-2 (ic50 = 20, 90, and 240 nm, respectively) and effectively suppresses vegf-stimulated proliferation of h... | |||
T8496 | MAZ51 | Apoptosis , VEGFR | |
MAZ51 is a VEGFR-3 (Flt-4) tyrosine kinase inhibitor. | |||
T8574 | SPHINX | Others | |
SPHINX is a new generation inhibitor of SPRK1 | |||
T4288 | HVEGF-IN-1 | VEGFR | |
hVEGF-IN-1 inhibits human VEGF-A translation and has antitumor activity. | |||
T15102 | Dexamethasone palmitate | DXP | Glucocorticoid Receptor |
Dexamethasone palmitate (DXP), a lipophilic prodrug of Dexamethasone, shows a 47-fold lower affinity for the glucocorticoid receptor than Dexamethasone. Dexamethasone palmitate is a glucocorticoid receptor agonist and an... | |||
T8973 | HS-1793 | Others | |
HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model | |||
T9715 | Aplidine | SARS-CoV , DNA/RNA Synthesis | |
Aplidine possesses antiviral activity against SARS-CoV-2(IC90 = 0.88 nM). Aplidine is a potent anti-cancer agent by targeting eukaryotic translation elongation factor 1 Alpha 2(EEF1A2, Kd = 80 nM). | |||
T9928 | Ranibizumab | VEGFR | |
Ranibizumab is a humanized monoclonal antibody fragment designed to target and inhibit vascular endothelial growth factor (VEGF), including VEGF110, VEGF121, and VEGF165. Ranibizumab's ability to selectively target and n... | |||
T0463 | Loxoprofen | Loxoprofene,Loxoprofeno,Koloxo | COX |
Loxoprofen (Koloxo) is an anti-inflammatory non-steroidal medicine. | |||
T8657 | KYP-2047 | Others | |
KYP-2047 is a very potent, selective Prolyl oligopeptidase (POP) inhibitor. | |||
T6182 | Tirofiban | L700462,Aggrastat,MK383 | Integrin |
Tirofiban (L700462) (MK-383) is a selective palate GPIIb/IIIa antagonist which inhibits platelet aggregation with IC50 of 9 nM. | |||
T1152 | Albendazole | SKF-62979 | HIF/HIF Prolyl-Hydroxylase , Microtubule Associated , Antibiotic , Parasite |
Albendazole (SKF-62979) is used as a drug indicated for the treatment of a variety of worm infestations. | |||
T2537 | Tirofiban hydrochloride monohydrate | Tirofiban Hydrochloride,MK-383 Hydrochloride | ATPase , Integrin |
Tirofiban hydrochloride monohydrate (MK-383 Hydrochloride) is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonist. | |||
TWA2417 | Sodium taurocholate | Taurocholate Sodium | Others |
Sodium taurocholate (Taurocholate Sodium) hydrate is the main end product of cholesterol catabolism. During enterohepatic circulation, bile taurocholic acid is converted by the microorganisms to taurodeoxycholic acid and... | |||
T72924 | VEGFR-3-IN-1 | VEGFR | |
VEGFR-3-IN-1 is a novel potent and selective VEGFR3 inhibitor with an IC50 of 110.4 nM.VEGFR-3-IN-1 possesses antitumor activity, inactivates the VEGFR3 signaling pathway, and inhibits the proliferation and migration of ... | |||
T37078 | VEGFR-2-IN-6 | VEGFR | |
VEGFR-2-IN-6 (WO 02/059110, example 64) is a potent inhibitor of VEGFR2, a crucial receptor involved in the regulation of angiogenesis [1]. | |||
T9979 | VEGFR-2-IN-29 | VEGFR | |
VEGFR-2-IN-29 is a VEGFR2 inhibitor. | |||
T10123 | VEGFR-2-IN-9 | KDR-in-4 | VEGFR |
VEGFR-2-IN-9 (KDR-in-4) is a potent KDR/VEGFR2 inhibitor (IC50: 7 nM). It can be used to study breast cancer. | |||
T61899 | VEGFR2-IN-1 | VEGFR | |
VEGFR2-IN-1 is a selective and potent VEGFR2 inhibitor with antitumor activity that inhibits cell proliferation and migration and can be used in the study of breast cancer. | |||
T2056 | VEGFR-2-IN-5 | 2, 4-Pyrimidinediamine with linker,UNC0064-12,2,4-Pyrimidinediamine with linker | VEGFR |
VEGFR-2-IN-5 (UNC0064-12), multikinase inhibitor and has a -NH2 terminal linker for further synthesis. |